Saturday, 19 April 2014

'21 Dead in Japan From New Johnson & Johnson Antipsychotic (Xeplion)' article on MIA

Mad in America article, 18 April 2014, '21 Dead in Japan From New Johnson & Johnson Antipsychotic (Xeplion)':

"The death toll among Japanese citizens who have taken Johnson & Johnson’s subsidiary Janssen’s schizophrenia drug Xeplion has climbed to 21, from 17 on April 10, prompting the Japanese health ministry to order the manufacturer to warn patients about its risks. Although a causal link between Xeplion and the deaths has not been established, the health ministry ordered Janssen to revise its package insert, considering the unusually high number of deaths since the drug’s recent release.

21 Users of Schizophrenia Drug Dead (Japan Times)"

"Among its (Xeplion) most frequently reported side effects are insomnia, headaches, respiratory tract infection, parkinsonism, increased weight, nausea, muscle and bone pain, tachycardia, tremors, abdominal pain, vomiting and diarrhea."


No comments:

Post a Comment